BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (XFOR) (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its ...
(RTTNews) - X4 Pharmaceuticals (XFOR), focused on rare immune system diseases, has announced a 1-for-30 reverse stock split of its common stock. The move was approved by the company's board and will ...
(RTTNews) - X4 Pharmaceuticals, Inc. (XFOR), Thursday, announced that its board of directors has approved a 1-for-30 reverse stock split of its common stock, effective on April 28, 2025. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results